New vaccine option tested for those who Can't take current shots
NCT ID NCT05279456
Summary
This study tested a different type of COVID-19 vaccine called SpikoGen, which is made using a protein-based method instead of mRNA. It involved 39 adults who had not received any prior COVID-19 vaccines. The main goal was to measure the body's immune response after two initial shots and a booster shot given at either one or three months later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARASMI
Adelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.